We have found that high PPRC1 expression significantly correlates with short overall survival (OS) in renal cancer (p < 0.0001; 877 patients), colon adenocarcinoma (p < 0.0092; 438 patients), lung adenocarcinoma (p < 0.033; 500 patients), and liver cancer (p < 0.0043; 365 patients) (Figure 7A–D). The gene discussed is PPRC1; the disease is liver cancer.